CANF

CANF CapEx to Revenue

0.49%TTM

Retrieved:

CANF FY CapEx/Revenue%
CANF FY CapEx/Revenue30.83%-3.30%
2010-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

CANF capex to revenue history

Capital expenditure as percentage of revenue. The available annual fiscal periods series contains 16 observations from Dec 31, 2010 to Dec 31, 2025.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.4941%
0.7418%
0.2692%
1.1111%
1.2896%
3.4076%
0.1476%
0.8639%
0.8174%
6.135%
27.5273%
0%
0%
0%
4.5378%
4.0469%

Compare capex to revenue

All CANF financial metrics · CANF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.